286 related articles for article (PubMed ID: 37807067)
1. PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression.
Taghehchian N; Maharati A; Akhlaghipour I; Zangouei AS; Moghbeli M
Cancer Cell Int; 2023 Oct; 23(1):233. PubMed ID: 37807067
[TBL] [Abstract][Full Text] [Related]
2. Kruppel-like factor 2 acts as a tumor suppressor in human retinoblastoma.
Wu N; Chen S; Luo Q; Jiang Z; Wang X; Li Y; Qiu J; Yu K; Yang Y; Zhuang J
Exp Eye Res; 2022 Mar; 216():108955. PubMed ID: 35074341
[TBL] [Abstract][Full Text] [Related]
3. Krüppel-like factor 2 suppresses human gastric tumorigenesis through inhibiting PTEN/AKT signaling.
Wang C; Li L; Duan Q; Wang Q; Chen J
Oncotarget; 2017 Nov; 8(59):100358-100370. PubMed ID: 29245984
[TBL] [Abstract][Full Text] [Related]
4. Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.
Taniguchi H; Jacinto FV; Villanueva A; Fernandez AF; Yamamoto H; Carmona FJ; Puertas S; Marquez VE; Shinomura Y; Imai K; Esteller M
Oncogene; 2012 Apr; 31(15):1988-94. PubMed ID: 21892211
[TBL] [Abstract][Full Text] [Related]
5. KLF2 Inhibits the Migration and Invasion of Prostate Cancer Cells by Downregulating MMP2.
Wang B; Liu M; Song Y; Li C; Zhang S; Ma L
Am J Mens Health; 2019; 13(1):1557988318816907. PubMed ID: 30520325
[TBL] [Abstract][Full Text] [Related]
6. KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway.
Li J; Jiang JL; Chen YM; Lu WQ
J Pathol Clin Res; 2023 Sep; 9(5):423-435. PubMed ID: 37147883
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
[TBL] [Abstract][Full Text] [Related]
8. Krüppel-like factor 2 suppresses growth and invasion of gastric cancer cells in vitro and in vivo.
Mao QQ; Chen JJ; Dong L; Zhong L; Sun X
J Biol Regul Homeost Agents; 2016; 30(3):703-712. PubMed ID: 27655487
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription.
Min J; Ma J; Wang Q; Yu D
Clinics (Sao Paulo); 2022; 77():100081. PubMed ID: 36087568
[TBL] [Abstract][Full Text] [Related]
11. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
12. Krüppel-Like Factor 2 Is a Gastric Cancer Suppressor and Prognostic Biomarker.
Li XM; Hu SJ; Liu JF; Ma MJ; Du LM; Bai FH
Evid Based Complement Alternat Med; 2023; 2023():2360149. PubMed ID: 36874616
[TBL] [Abstract][Full Text] [Related]
13. Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells.
Maharati A; Samsami Y; Latifi H; Tolue Ghasaban F; Moghbeli M
Cancer Cell Int; 2023 Aug; 23(1):168. PubMed ID: 37580768
[TBL] [Abstract][Full Text] [Related]
14. Kruppel-like Factor 2 Inhibits Proliferation in Renal Angiomyolipoma
Liu CY; Chang TH; Hsieh CH; Chang YH; Pang JS; Chuang CK
Anticancer Res; 2022 Oct; 42(10):4753-4762. PubMed ID: 36191984
[TBL] [Abstract][Full Text] [Related]
15. KLF2 is downregulated in pancreatic ductal adenocarcinoma and inhibits the growth and migration of cancer cells.
Zhang D; Dai Y; Cai Y; Suo T; Liu H; Wang Y; Cheng Z; Liu H
Tumour Biol; 2016 Mar; 37(3):3425-31. PubMed ID: 26449825
[TBL] [Abstract][Full Text] [Related]
16. Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
Lu L; Huang W; Hu W; Jiang L; Li Y; Wu X; Yuan D; Li M
Biochem Biophys Res Commun; 2019 Apr; 511(4):772-779. PubMed ID: 30833076
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of tumor-derived extracellular vesicles in prostatic cancer progression through the circFMN2/KLF2/RNF128 axis.
Huang S; Zhao J; Yu H; Chen G
Apoptosis; 2023 Oct; 28(9-10):1372-1389. PubMed ID: 37452271
[TBL] [Abstract][Full Text] [Related]
18. The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy.
Dabravolski SA; Sukhorukov VN; Kalmykov VA; Grechko AV; Shakhpazyan NK; Orekhov AN
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203463
[TBL] [Abstract][Full Text] [Related]
19. Histone and DNA methylation-mediated epigenetic downregulation of endothelial Kruppel-like factor 2 by low-density lipoprotein cholesterol.
Kumar A; Kumar S; Vikram A; Hoffman TA; Naqvi A; Lewarchik CM; Kim YR; Irani K
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1936-42. PubMed ID: 23723375
[TBL] [Abstract][Full Text] [Related]
20. Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium.
Kawanami D; Mahabeleshwar GH; Lin Z; Atkins GB; Hamik A; Haldar SM; Maemura K; Lamanna JC; Jain MK
J Biol Chem; 2009 Jul; 284(31):20522-30. PubMed ID: 19491109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
